TriSalus Life Sciences (TLSI) FCF Margin (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly FCF Margin of 74.4% for Q1 2026, down 2437.0% year-over-year from 3.18% in Q1 2025, and down 486.55% quarter-over-quarter from 12.68% in Q4 2025.
TriSalus Life Sciences (TLSI) FCF Margin (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' FCF Margin history runs 5 years deep, the most recent figure standing at 74.4% for Q1 2026.
- In Q1 2026, FCF Margin fell 2437.0% year-over-year to 74.4%; the TTM figure through Mar 2026 stood at 44.82% (up 6251.0% YoY), while the FY2025 annual figure was 40.04%, up 9873.0% from the prior year.
- FCF Margin for Q1 2026 stood at 74.4%, down from 12.68% in the prior quarter.
- The five-year high for FCF Margin was 12.68% in Q4 2025, with the low at 583.23% in Q3 2022.
- The 5-year median for FCF Margin is 166.91% (2023), against an average of 185.13%.
- The sharpest annual moves came in 2024 and 2026: FCF Margin soared 27067 bps in 2024, then sank 2437 bps in 2026.
- TriSalus Life Sciences' FCF Margin stood at 243.99% in 2022, then surged by 32 bps to 166.91% in 2023, then soared by 61 bps to 65.51% in 2024, then jumped by 81 bps to 12.68% in 2025, then tumbled by 487 bps to 74.4% in 2026.
- Business Quant data shows TLSI's FCF Margin at 74.4% in Q1 2026, 12.68% in Q4 2025, and 39.48% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 15.81% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 16.07% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 21.26% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 23.50% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 33.60% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 14.10% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 1.28% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 5.32% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 18.73% |
| 10 | TriSalus Life Sciences | 307.81 Mn | 261.52 Mn | 9.90 Mn | -89.52% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -89.52% |
| Mar 31, 2026 | -74.40% |
| Dec 31, 2025 | -12.68% |
| Sep 30, 2025 | -39.48% |
| Jun 30, 2025 | -64.68% |
| Mar 31, 2025 | -50.03% |
| Dec 31, 2024 | -65.51% |
| Sep 30, 2024 | -149.90% |
| Jun 30, 2024 | -183.08% |
| Mar 31, 2024 | -169.32% |
| Dec 31, 2023 | -166.91% |
| Sep 30, 2023 | -420.57% |
| Jun 30, 2023 | -200.93% |
| Mar 31, 2023 | -352.21% |
| Dec 31, 2022 | -243.99% |
| Sep 30, 2022 | -583.23% |